It was originally isolated in 1977 from the cerebral venous blood of rabbits and has since been found to be present in small amounts in human brains and plasma, with higher concentrations later in the day.3 4 It, or a similar substance, is also present at higher concentrations in human breast milk.5 Because DSIP can cross the blood-brain barrier and is easily absorbed via the gut (unusual for a peptide), some researchers have hypothesized that it may facilitate post-feeding sleep tendencies among newborns, though it remains unclear whether DSIP truly has a hand in neonate sleep-wake cycles.4 5 6 Its mechanism of action is likewise unclear, but it may have something to do with endocrine regulation
Medical disclaimer: This content is educational and does not replace individualized medical advice, diagnosis, or treatment
The single most common complaint about research-grade peptides in Thailand is inconsistency between batches
It is possible that you are not losing weight on semaglutide for several reasons
Modern GLP-1 medications are designed to mimic this exact hormone, but with a longer-lasting effect
The company also plans to study whether its possible for patients to maintain their weight loss after stopping the medication but expects it to be a chronic therapy for the foreseeable future
